Dr. Seth Snyder focuses on preparing and prosecuting domestic and foreign patent applications in various technical areas, including medicinal and process chemistry, biotechnology, antibodies, immunotherapy, oncology, gene therapy, materials chemistry, drug delivery, diagnostics, batteries, and alternative fuels.
Seth has experience overseeing patent portfolios for international, midsize, and startup companies and advises biotechnology, pharmaceutical, and university clients on lifecycle management of marketed drug products and clinical candidates. In particular, Seth advises clients developing portfolios around small molecule therapeutics, monoclonal antibodies, biofuels, and personalized medicine. He also performs due diligence reviews of patent portfolios in transactions, including public offerings and acquisitions.